About Ramy Farid
Form D filings for Ajax Therapeutics from 2019 to 2024 list Ramy Farid as director.
Ramy Farid first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Ramy Farid in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ramy Farid works with at each company, as listed on that company's latest Form D.
Ajax Therapeutics, Inc. · Form D, May 13, 2024